WHITEPAPER: MARKET ACCESS
Reimbursement for Software in Hospitals (2026)
Monetizing Medical Device Software in Inpatient Care in Germany
Last updated: April 2026
Contents
- Regulatory framework
- Prior approval vs. permission unless prohibited
- The DRG system explained simply
- Remuneration in the inpatient sector: DRG, supplementary fees (ZE) & NUB
- Bridging solutions until regular financing
- Practical examples
Whether AI-based diagnostic software or digital decision support systems: Medical software products are increasingly making their way into German hospitals.
But their success depends not only on clinical benefit, but also on the right financing strategy. For manufacturers, the question is: How do you achieve market access in the inpatient sector, and which billing pathways are open to you?
This whitepaper explains inpatient reimbursement of software as a medical device: from the DRG flat-rate case fee to the NUB procedure. You will also learn which bridging solutions exist, such as the Krankenhauszukunftsgesetz (KHZG, Hospital Future Act), and what fundamental differences there are compared to the outpatient reimbursement logic in Germany.


